Literature DB >> 18312296

Melatonin prevents the injury-induced decline of Akt/forkhead transcription factors phosphorylation.

Phil-Ok Koh1.   

Abstract

Melatonin plays a neuroprotective role against brain injury through the activation of Akt and the inhibition of apoptotic cell death. This study investigated whether melatonin modulates the anti-apoptotic signal through the activation of Akt and its downstream targets, FKHR, AFX, and 14-3-3. Adult male rats were treated with melatonin (5 mg/kg) prior to middle cerebral artery occlusion (MCAO) and brain tissues were collected at 24 hr after MCAO. This study confirmed that melatonin significantly reduces infarct volume and decreases the number of TUNEL-positive cells in the cerebral cortex. Potential activation was measured by phosphorylation of PDK1 at Ser(241), Akt at Ser(473), FKHR at Ser(256), and AFX at Ser(193) using Western blot analysis. Melatonin prevented the injury-induced reduction of pPDK1, pAkt, pFKHR, and pAFX. However, melatonin did not affect the level of 14-3-3, which acts as an anti-apoptotic factor through interaction of pFKHR. Further, in the presence of melatonin, the interaction of pFKHR and 14-3-3 increased, compared with that of control animals. This study suggests that melatonin plays a potent protective role against brain injury and that Akt activation and FKHR phosphorylation by melatonin mediated these protective effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312296     DOI: 10.1111/j.1600-079X.2008.00577.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  8 in total

Review 1.  Central nervous system agents for ischemic stroke: neuroprotection mechanisms.

Authors:  Rachna S Pandya; Lijuan Mao; Hua Zhou; Shuanhu Zhou; Jiang Zeng; A John Popp; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

2.  The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors.

Authors:  Arabinda Das; Misty McDowell; Matthew J Pava; Joshua A Smith; Russel J Reiter; John J Woodward; Abhay K Varma; Swapan K Ray; Naren L Banik
Journal:  J Pineal Res       Date:  2010-01-17       Impact factor: 13.007

Review 3.  The antiapoptotic activity of melatonin in neurodegenerative diseases.

Authors:  Xin Wang
Journal:  CNS Neurosci Ther       Date:  2009-10-10       Impact factor: 5.243

Review 4.  Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Olatz Arteaga; Agustín Martínez-Ibargüen; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

Review 5.  Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review.

Authors:  Sichao Guo; Ruchi Mangal; Chaitu Dandu; Xiaokun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

6.  Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

Authors:  Alejandro Romero; Eva Ramos; Paloma Patiño; Maria J Oset-Gasque; Francisco López-Muñoz; José Marco-Contelles; María I Ayuso; Alberto Alcázar
Journal:  Front Aging Neurosci       Date:  2016-11-23       Impact factor: 5.750

7.  Melatonin regulates the aging mouse hippocampal homeostasis via the sirtuin1-FOXO1 pathway.

Authors:  Anorut Jenwitheesuk; Parichart Boontem; Prapimpun Wongchitrat; Jiraporn Tocharus; Sujira Mukda; Piyarat Govitrapong
Journal:  EXCLI J       Date:  2017-03-23       Impact factor: 4.068

Review 8.  Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways.

Authors:  Anorut Jenwitheesuk; Chutikorn Nopparat; Sujira Mukda; Prapimpun Wongchitrat; Piyarat Govitrapong
Journal:  Int J Mol Sci       Date:  2014-09-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.